Supplementary Material
Table S1. Baseline characteristics of participants.Case / Gender / Age
(years) / Location of
Lesion / Group / Lesion diameter*
(mm) / Clinical symptoms
001 / F / 67 / L,P / P / 16 / Numbness (right extremity)
002 / M / 47 / R,P / P / 9 / Numbness (left extremity)
003 / F / 61 / R,P / P / 19 / Numbness (left extremity)
004 / M / 65 / R,P / P / 7 / Numbness (left extremity)
005 / F / 54 / R,P / P / 10 / Numbness (left extremity)
006 / M / 43 / L,Th / P / 10 / Numbness (right extremity)
007 / F / 58 / L,Th / P / 11 / Numbness (right extremity)
008 / M / 43 / L,Th / P / 9 / Numbness (right extremity)
009 / F / 67 / H
010 / F / 62 / H
011 / F / 73 / H
012 / M / 59 / H
013 / M / 45 / H
014 / M / 70 / H
015 / M / 66 / H
016 / M / 73 / H
017 / F / 56 / H
018 / M / 59 / H
019 / F / 56 / H
020 / F / 55 / H
021 / M / 55 / H
022 / F / 48 / H
023 / F / 46 / H
024 / F / 46 / H
025 / F / 50 / H
026 / F / 52 / H
027 / F / 60 / H
*largest axial lesion diameter; M, male; F, female; L, left; R, right; P, pons; T, Thalamus;
Fig. S1. Mean ReHo value in the stroke area (large ROI covering all stroke areas) in the P (stroke patients) and H groups (healthy controls). The P group had a lower ReHo in the stroke area than H group (P = 0.02) (*P <0.05).
Fig. S2. Changes in topological properties. There were no significant differences in clustering coefficient (Cp), shortest path length (Lp), local efficiency (Eloc). and global efficiency (Eg) between P (stroke patients) and H groups (healthy controls).